検索結果 - Richárd Márkus

  • 検索結果 1 - 7 結果 / 7
結果の絞り込み
  1. 1
    A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects

    A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects 著者: Vladimir Hanes, Vincent Chow, Nan Zhang, Richárd Márkus

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab

    A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab 著者: Primal Kaur, Vincent Chow, Nan Zhang, Michael Moxness, Arunan Kaliyaperumal, Richárd Márkus

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community

    Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community 著者: Richárd Márkus, Jennifer Liu, Monica Ramchandani, Diana Landa, Teresa L. Born, Primal Kaur

    出版事項 2017
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Estimation of Cachexia among Cancer Patients Based on Four Definitions

    Estimation of Cachexia among Cancer Patients Based on Four Definitions 著者: Kathleen M. Fox, John M. Brooks, Shravanthi R. Gandra, Richárd Márkus, Chiun‐Fang Chiou

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

    Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial 著者: Gabriela Senti, Bettina M. Prinz Vavricka, Iris Erdmann, Mella I. Diaz, Richárd Márkus, Stephen J. McCormack, John Simard, Brunello Wüthrich, Reto Crameri, Nicole Graf, Pål Johansen, Thomas M. Kündig

    出版事項 2008
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis

    Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis 著者: Ronald L. Gibson, George Retsch‐Bogart, Christopher M. Oermann, Carlos Milla, Joseph M. Pilewski, Cori Daines, Richard C. Ahrens, Kevin León, Morty Cohen, Sharon McNamara, Tracy L. Callahan, Richárd Márkus, Jane L. Burns

    出版事項 2006
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives

    NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives 著者: Andrew D. Zelenetz, Islah Ahmed, Edward L. Braud, James D. Cross, Nancy Davenport-Ennis, Barry D. Dickinson, Steven E. Goldberg, Scott Gottlieb, Philip E. Johnson, Gary H. Lyman, Richárd Márkus, Ursula A. Matulonis, Denise K. Reinke, Edward C. Li, Jessica K. DeMartino, Jonathan K. Larsen, James M. Hoffman

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: